We are live on ! Find out more
PRAH

PRA Health Sciences, Inc.
PRAH

Delisted

PRAH was delisted on the 30th of June, 2021.

293 hedge funds and large institutions have $6.06B invested in PRA Health Sciences, Inc. in 2020 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 100 increasing their positions, 124 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

234% more call options, than puts

Call options by funds: $8.86M | Put options by funds: $2.65M

16% more capital invested

Capital invested by funds: $5.24B → $6.06B (+$821M)

3% less funds holding

Funds holding: 301293 (-8)

16% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 45

19% less repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 124

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
293
Holders Change
-8
Holders Change %
-2.66%
% of All Funds
6.01%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
38
Increased
100
Reduced
124
Closed
45
Calls
$8.86M
Puts
$2.65M
Net Calls
+$6.21M
Net Calls Change
+$1.74M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$714M -$3.58M -38,474 -0.5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$665M -$15.3M -164,873 -2%
BlackRock
3
BlackRock
New York
$642M +$29.9M +321,542 +5%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$531M -$25.2M -270,477 -5%
Massachusetts Financial Services
5
Massachusetts Financial Services
Massachusetts
$443M +$174M +1,864,740 +69%
Capital Research Global Investors
6
Capital Research Global Investors
California
$309M -$12M -129,195 -4%
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$193M +$2.09M +22,452 +1%
State Street
8
State Street
Massachusetts
$146M +$1.88M +20,164 +1%
NIPH
9
NN Investment Partners Holdings
Netherlands
$144M +$3.38M +36,284 +3%
PG
10
Pendal Group
Australia
$99.9M -$2.49M -26,783 -3%
Ameriprise
11
Ameriprise
Minnesota
$92.4M -$4.29M -46,127 -5%
Invesco
12
Invesco
Georgia
$79.2M +$3.06M +32,892 +4%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$74.3M +$2.39M +25,643 +3%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$73M +$6.62M +71,166 +10%
Loomis, Sayles & Company
15
Loomis, Sayles & Company
Massachusetts
$65.9M +$5.32M +57,148 +9%
BAMCO Inc
16
BAMCO Inc
New York
$63.7M -$14M -150,000 -19%
VNIM
17
Vaughan Nelson Investment Management
Texas
$62.7M -$10.2M -109,454 -15%
Norges Bank
18
Norges Bank
Norway
$59.9M -$3.45M -37,027 -6%
AQR Capital Management
19
AQR Capital Management
Connecticut
$57.1M +$2.21M +23,719 +4%
Goldman Sachs
20
Goldman Sachs
New York
$56.4M -$3.98M -42,731 -7%
TCM
21
TimesSquare Capital Management
New York
$56M +$31.2M +335,660 +140%
VOYA Investment Management
22
VOYA Investment Management
Georgia
$55.2M +$43.2M +463,872 +450%
SIMG
23
Stephens Investment Management Group
Texas
$53.9M +$113K +1,219 +0.2%
Northern Trust
24
Northern Trust
Illinois
$50.8M +$869K +9,333 +2%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$49.5M +$2.21M +23,719 +5%

PRAH Hedge Fund Activity: Q2 2020 in Review

293 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q2 2020, worth a combined $6.06B — up 16% from $5.24B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of PRAH and 38 opened new positions — a net loss of 7 holders — while 124 trimmed existing stakes and 100 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $174M. The largest seller was Eagle Asset Management, cutting an estimated $51.5M.

  • 293 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q2 2020, down from 301 in Q1 2020.
  • Funds reported $6.06B of PRA Health Sciences, Inc. stock for Q2 2020, up 16% quarter-over-quarter.
  • 38 funds opened new PRA Health Sciences, Inc. positions in Q2 2020 and 45 closed out, a net change of -7 holders.
  • The largest PRA Health Sciences, Inc. buyer in Q2 2020 was Massachusetts Financial Services, an estimated $174M added.
  • The largest PRA Health Sciences, Inc. seller in Q2 2020 was Eagle Asset Management, an estimated $51.5M sold.

Based on aggregated 13F filings for Q2 2020.